Literature DB >> 16520211

Perioperative morbidity and mortality after reconstruction for metastatic tumors of the proximal femur and acetabulum.

Robert H Quinn1, Jessica Drenga.   

Abstract

An observational cohort study was performed on 90 hip arthroplasties performed in 84 patients for metastatic disease of the hip. Significant improvement was noted with both 3-month and 6-month function scores vs preoperative function scores (P < .001). Complications included 1 intraoperative femur fracture, 2 cases of deep venous thrombosis, 1 peroneal nerve palsy, 1 deep infection, and 5 dislocations. Eight (8.8% of 90 procedures, 9.4% of 84 patients) patients died during the initial hospital stay. Although the risk of mortality after hip arthroplasty for metastatic diseases is perhaps higher than previously expected, improvement in postoperative function scores in surviving patients was significant and perioperative morbidity in this complex patient population was acceptably low.

Entities:  

Mesh:

Year:  2006        PMID: 16520211     DOI: 10.1016/j.arth.2005.04.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  [Management of complications following resection and defect reconstruction of tumors near the hip joint].

Authors:  K-D Schaser; I Melcher; S Märdian; C Perka; R Locher; P Schwabe
Journal:  Orthopade       Date:  2014-01       Impact factor: 1.087

Review 2.  [Metastatic disease in long bones : Review of surgical treatment options].

Authors:  Franz Liska; Philipp Schmitz; Norbert Harrasser; Peter Prodinger; Hans Rechl; Rüdiger von Eisenhart-Rothe
Journal:  Unfallchirurg       Date:  2018-01       Impact factor: 1.000

3.  Evaluation of prognostic scoring systems for bone metastases using single-center data.

Authors:  Hirofumi Shimada; Takao Setoguchi; Shunsuke Nakamura; Masahiro Yokouchi; Yasuhiro Ishidou; Hiroyuki Tominaga; Ichiro Kawamura; Satoshi Nagano; Setsuro Komiya
Journal:  Mol Clin Oncol       Date:  2015-09-04

4.  How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.

Authors:  Andrea Piccioli; M Silvia Spinelli; Jonathan A Forsberg; Rikard Wedin; John H Healey; Vincenzo Ippolito; Primo Andrea Daolio; Pietro Ruggieri; Giulio Maccauro; Alessandro Gasbarrini; Roberto Biagini; Raimondo Piana; Flavio Fazioli; Alessandro Luzzati; Alberto Di Martino; Francesco Nicolosi; Francesco Camnasio; Michele Attilio Rosa; Domenico Andrea Campanacci; Vincenzo Denaro; Rodolfo Capanna
Journal:  BMC Cancer       Date:  2015-05-22       Impact factor: 4.430

5.  Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort.

Authors:  Michala Skovlund Sørensen; Klaus Hindsø; Thea Bechmann Hovgaard; Michael Mørk Petersen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Outcome after Surgery for Metastases to the Pelvic Bone: A Single Institutional Experience.

Authors:  Chandra Kumar Krishnan; Ilkyu Han; Han-Soo Kim
Journal:  Clin Orthop Surg       Date:  2017-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.